Multiple-Locus Variable-Number Tandem-Repeat Analysis of Mycoplasma pneumoniae Isolates between 2004 and 2014 in Yamagata, Japan: Change in Molecular Characteristics during an 11-year Period
Multiple-locus variable-number tandem-repeat analysis (MLVA) typing was performed for Mycoplasma pneumoniae strains isolated between 2004 and 2014 in Yamagata, Japan. The results were examined by considering the combination of the P1 type and prevalence of macrolide resistance-associated mutations....
Saved in:
Published in | Japanese Journal of Infectious Diseases Vol. 70; no. 6; pp. 642 - 646 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee
2017
Japan Science and Technology Agency |
Subjects | |
Online Access | Get full text |
ISSN | 1344-6304 1884-2836 1884-2836 |
DOI | 10.7883/yoken.JJID.2017.276 |
Cover
Loading…
Abstract | Multiple-locus variable-number tandem-repeat analysis (MLVA) typing was performed for Mycoplasma pneumoniae strains isolated between 2004 and 2014 in Yamagata, Japan. The results were examined by considering the combination of the P1 type and prevalence of macrolide resistance-associated mutations. Four-locus (Mpn13–16) MLVA classified 347 strains into 9 MLVA types, including 3 major types: 3-5-6-2, 4-5-7-2, and 4-5-7-3. All type 3-5-6-2 strains (77 strains) were P1 type 2 variants (2a or 2c), while types 4-5-7-2 (181 strains) and 4-5-7-3 (75 strains) were P1 type 1. MLVA type 4-5-7-2 strains circulated and were dominant until 2010, accounting for 88.4% of the 121 strains isolated between 2004 and 2010. The prevalence of types 4-5-7-3 and 3-5-6-2 strains increased rapidly in 2011 and 2012, respectively, resulting in cocirculation of 3 MLVA types, including type 4-5-7-2, between 2011 and 2013. The prevalence of macrolide resistance-associated mutations in MLVA types 4-5-7-2, 4-5-7-3, and 3-5-6-2 strains was 59.7% (108/181), 25.3% (19/75), and 0% (0/77), respectively. Because the prevalence of macrolide resistance-associated mutations differed by current MLVA types in Yamagata, continued surveillance combined with molecular typing and identification of macrolide resistance-associated mutations is necessary. |
---|---|
AbstractList | Multiple-locus variable-number tandem-repeat analysis (MLVA) typing was performed for Mycoplasma pneumoniae strains isolated between 2004 and 2014 in Yamagata, Japan. The results were examined by considering the combination of the P1 type and prevalence of macrolide resistance-associated mutations. Four-locus (Mpn13–16) MLVA classified 347 strains into 9 MLVA types, including 3 major types: 3-5-6-2, 4-5-7-2, and 4-5-7-3. All type 3-5-6-2 strains (77 strains) were P1 type 2 variants (2a or 2c), while types 4-5-7-2 (181 strains) and 4-5-7-3 (75 strains) were P1 type 1. MLVA type 4-5-7-2 strains circulated and were dominant until 2010, accounting for 88.4% of the 121 strains isolated between 2004 and 2010. The prevalence of types 4-5-7-3 and 3-5-6-2 strains increased rapidly in 2011 and 2012, respectively, resulting in cocirculation of 3 MLVA types, including type 4-5-7-2, between 2011 and 2013. The prevalence of macrolide resistance-associated mutations in MLVA types 4-5-7-2, 4-5-7-3, and 3-5-6-2 strains was 59.7% (108/181), 25.3% (19/75), and 0% (0/77), respectively. Because the prevalence of macrolide resistance-associated mutations differed by current MLVA types in Yamagata, continued surveillance combined with molecular typing and identification of macrolide resistance-associated mutations is necessary. Multiple-locus variable-number tandem-repeat analysis (MLVA) typing was performed for Mycoplasma pneumoniae strains isolated between 2004 and 2014 in Yamagata, Japan. The results were examined by considering the combination of the P1 type and prevalence of macrolide resistance-associated mutations. Four-locus (Mpn13-16) MLVA classified 347 strains into 9 MLVA types, including 3 major types: 3-5-6-2, 4-5-7-2, and 4-5-7-3. All type 3-5-6-2 strains (77 strains) were P1 type 2 variants (2a or 2c), while types 4-5-7-2 (181 strains) and 4-5-7-3 (75 strains) were P1 type 1. MLVA type 4-5-7-2 strains circulated and were dominant until 2010, accounting for 88.4% of the 121 strains isolated between 2004 and 2010. The prevalence of types 4-5-7-3 and 3-5-6-2 strains increased rapidly in 2011 and 2012, respectively, resulting in cocirculation of 3 MLVA types, including type 4-5-7-2, between 2011 and 2013. The prevalence of macrolide resistance-associated mutations in MLVA types 4-5-7-2, 4-5-7-3, and 3-5-6-2 strains was 59.7% (108/181), 25.3% (19/75), and 0% (0/77), respectively. Because the prevalence of macrolide resistance-associated mutations differed by current MLVA types in Yamagata, continued surveillance combined with molecular typing and identification of macrolide resistance-associated mutations is necessary.Multiple-locus variable-number tandem-repeat analysis (MLVA) typing was performed for Mycoplasma pneumoniae strains isolated between 2004 and 2014 in Yamagata, Japan. The results were examined by considering the combination of the P1 type and prevalence of macrolide resistance-associated mutations. Four-locus (Mpn13-16) MLVA classified 347 strains into 9 MLVA types, including 3 major types: 3-5-6-2, 4-5-7-2, and 4-5-7-3. All type 3-5-6-2 strains (77 strains) were P1 type 2 variants (2a or 2c), while types 4-5-7-2 (181 strains) and 4-5-7-3 (75 strains) were P1 type 1. MLVA type 4-5-7-2 strains circulated and were dominant until 2010, accounting for 88.4% of the 121 strains isolated between 2004 and 2010. The prevalence of types 4-5-7-3 and 3-5-6-2 strains increased rapidly in 2011 and 2012, respectively, resulting in cocirculation of 3 MLVA types, including type 4-5-7-2, between 2011 and 2013. The prevalence of macrolide resistance-associated mutations in MLVA types 4-5-7-2, 4-5-7-3, and 3-5-6-2 strains was 59.7% (108/181), 25.3% (19/75), and 0% (0/77), respectively. Because the prevalence of macrolide resistance-associated mutations differed by current MLVA types in Yamagata, continued surveillance combined with molecular typing and identification of macrolide resistance-associated mutations is necessary. |
Author | Matsuzaki, Yoko Itagaki, Tsutomu Ikeda, Tatsuya Katsushima, Fumio Suzuki, Yu Seto, Junji Katsushima, Yuriko Hongo, Seiji Mizuta, Katsumi Shimotai, Yoshitaka |
Author_xml | – sequence: 1 fullname: Shimotai, Yoshitaka organization: Department of Infectious Diseases, Yamagata University Faculty of Medicine – sequence: 1 fullname: Itagaki, Tsutomu organization: Yamanobe Pediatric Clinic – sequence: 1 fullname: Mizuta, Katsumi organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health – sequence: 1 fullname: Suzuki, Yu organization: Department of Infectious Diseases, Yamagata University Faculty of Medicine – sequence: 1 fullname: Ikeda, Tatsuya organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health – sequence: 1 fullname: Hongo, Seiji organization: Department of Infectious Diseases, Yamagata University Faculty of Medicine – sequence: 1 fullname: Seto, Junji organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health – sequence: 1 fullname: Matsuzaki, Yoko organization: Department of Infectious Diseases, Yamagata University Faculty of Medicine – sequence: 1 fullname: Katsushima, Fumio organization: Katsushima Pediatric Clinic – sequence: 1 fullname: Katsushima, Yuriko organization: Katsushima Pediatric Clinic |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29093323$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkd2O0zAQhSO0iP2BJ0BClrjhghQ7dhKHu1X5a9UCQgsSV9HEmRYvjh1sR6gvx7Ph0lKJveFmbM9851iac5mdWWcxyx4zOqul5C927jva2XK5eDUrKKtnRV3dyy6YlCIvJK_O0p0LkVecivPsMoRbSouyZPRBdl40tOG84BfZr_Vkoh4N5iunpkC-gNfQpef7aejQkxuwPQ75JxwRIrm2YHZBB-I2ZL1TbjQQBiCjxWlwVgOSRXAGIgbSYfyJaElBqSDJJF2YINqSrzDAFiI8J0sYwb4k829gt7gfrZ1BNRnw-54HFdHrELUKpJ-8ttvkQxjLd5iIj2nm-ofZ_Q2YgI-O51X2-c3rm_m7fPXh7WJ-vcpVxWTMN10joek5LzHVBqQCCr2EvgLguOmYrCtWlV1fVEXdybIWsldCNiWtlEg9fpU9O_iO3v2YMMR20EGhMWDRTaFlTdnwgklRJfTpHfTWTT4tLrRpBZyJRjQyUU-O1NQN2Lej1wP4Xfs3mQTwA6C8C8Hj5oQw2u7zb__k3-7z3xvXbco_qZo7KqUjRO1s9KDNf7SLg_Y2RNji6T_wKQKDR01N22pf_tGeGJVya9Hy39ca0lo |
CitedBy_id | crossref_primary_10_1016_j_jfma_2022_05_001 crossref_primary_10_3389_fcimb_2021_675466 crossref_primary_10_1016_j_jgar_2021_10_003 crossref_primary_10_1089_mdr_2018_0295 crossref_primary_10_1099_jmm_0_000969 crossref_primary_10_1128_JCM_00049_19 crossref_primary_10_1016_j_jfma_2019_12_008 crossref_primary_10_1093_ofid_ofab416 crossref_primary_10_1128_JCM_00710_20 crossref_primary_10_3201_eid2408_180081 crossref_primary_10_1016_j_ijid_2019_03_028 crossref_primary_10_1016_j_ijmmb_2023_100435 crossref_primary_10_1371_journal_pone_0209938 crossref_primary_10_3390_jcm11030715 crossref_primary_10_1007_s10096_019_03717_6 |
Cites_doi | 10.1099/jmm.0.046441-0 10.1371/journal.pone.0174701 10.1128/JCM.03366-13 10.1097/00006454-199506000-00002 10.1128/AAC.48.2.460-465.2004 10.1128/JCM.00105-11 10.11150/kansenshogakuzasshi.89.16 10.1128/JCM.00350-17 10.1093/ofid/ofv106 10.1086/511159 10.7883/yoken.JJID.2014.336 10.1371/journal.pone.0082174 10.1128/JCM.01983-15 10.1128/JCM.01156-15 10.3389/fmicb.2016.00974 10.1097/INF.0b013e31827aa7bd 10.1111/j.1574-6976.2008.00129.x 10.1128/JCM.01935-08 10.1093/clinids/17.Supplement_1.S37 10.2217/fmb-2016-0111 10.1017/S0950268899003313 10.1371/journal.pone.0170253 10.3201/eid2103.140927 10.1128/JCM.02597-14 10.1371/journal.pone.0064607 10.1128/JCM.34.2.447-449.1996 10.1111/j.1348-0421.2001.tb01293.x 10.1016/j.nmni.2015.05.005 10.1128/JB.06553-11 10.1128/CMR.17.4.697-728.2004 10.1111/j.1440-1843.2003.00522.x |
ContentType | Journal Article |
Copyright | Authors Copyright Japan Science and Technology Agency 2017 |
Copyright_xml | – notice: Authors – notice: Copyright Japan Science and Technology Agency 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7T5 7T7 7TK 7U9 8FD C1K FR3 H94 M7N P64 7X8 |
DOI | 10.7883/yoken.JJID.2017.276 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Virology and AIDS Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1884-2836 |
EndPage | 646 |
ExternalDocumentID | 29093323 10_7883_yoken_JJID_2017_276 article_yoken_70_6_70_JJID_2017_276_article_char_en |
Genre | Historical Article Journal Article |
GeographicLocations | Japan |
GeographicLocations_xml | – name: Japan |
GroupedDBID | --- .55 29J 2WC 3O- 53G 5GY 7.U ACPRK ADBBV AENEX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL DIK DU5 E3Z EBS EJD F5P FRP GX1 JSF JSH KQ8 OK1 OVT RJT RNS RZJ TR2 W2D X7M XSB ZXP AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7T5 7T7 7TK 7U9 8FD C1K FR3 H94 M7N P64 7X8 |
ID | FETCH-LOGICAL-c618t-fb98a9d335e9d39a8ca0ad8ad6aa3efb1876165bd2627b85748dc489506c42623 |
ISSN | 1344-6304 1884-2836 |
IngestDate | Thu Jul 10 19:54:46 EDT 2025 Mon Jun 30 12:03:05 EDT 2025 Thu Jan 02 23:10:19 EST 2025 Tue Jul 01 03:55:13 EDT 2025 Thu Apr 24 22:58:35 EDT 2025 Wed Sep 03 06:30:23 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | P1 type molecular epidemiology MLVA VNTR macrolide resistance |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c618t-fb98a9d335e9d39a8ca0ad8ad6aa3efb1876165bd2627b85748dc489506c42623 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/yoken/70/6/70_JJID.2017.276/_article/-char/en |
PMID | 29093323 |
PQID | 2013149498 |
PQPubID | 2048383 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_1959321846 proquest_journals_2013149498 pubmed_primary_29093323 crossref_primary_10_7883_yoken_JJID_2017_276 crossref_citationtrail_10_7883_yoken_JJID_2017_276 jstage_primary_article_yoken_70_6_70_JJID_2017_276_article_char_en |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-00-00 |
PublicationDateYYYYMMDD | 2017-01-01 |
PublicationDate_xml | – year: 2017 text: 2017-00-00 |
PublicationDecade | 2010 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan – name: Tokyo |
PublicationTitle | Japanese Journal of Infectious Diseases |
PublicationTitleAlternate | Jpn J Infect Dis |
PublicationYear | 2017 |
Publisher | National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee Japan Science and Technology Agency |
Publisher_xml | – name: National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee – name: Japan Science and Technology Agency |
References | 3. Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis. 1993;17:S37-46. 10. Ho PL, Law PY, Chan BW, et al. Emergence of macrolide-resistant Mycoplasma pneumoniae in Hong Kong is linked to increasing macrolide resistance in multilocus variable-number tandem-repeat analysis type 4-5-7-2. J Clin Microbiol. 2015;53:3560-4. 5. Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology. 2004;9:109-14. 31. Whistler T, Sawatwong P, Diaz MH, et al. Molecular characterization of Mycoplasma pneumoniae infections in two rural populations of Thailand from 2009 to 2012. J Clin Microbiol. 2017;55:2222-33. 12. Sun H, Xue G, Yan C, et al. Multiple-locus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature. PLoS One. 2013;8:e64607. 18. Pereyre S, Goret J, Bébéar C. Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment. Front Microbiol. 2016;7:974. 15. Kenri T, Horino A, Matsui M, et al. Complete genome sequence of Mycoplasma pneumoniae type 2a strain 309, isolated in Japan. J Bacteriol. 2012;194:1253-4. 6. Dégrange S, Cazanave C, Charron A, et al. Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae. J Clin Microbiol. 2009;47:914-23. 14. Sasaki T, Kenri T, Okazaki N, et al. Epidemiological study of Mycoplasma pneumoniae infections in Japan based on PCR-restriction fragment length polymorphism of the P1 cytadhesin gene. J Clin Microbiol 1996;34:447-9. 33. Zhang J, Song X, Ma MJ, et al. Inter- and intra-strain variability of tandem repeats in Mycoplasma pneumoniae based on next-generation sequencing data. Future Microbiol. 2017;12:119-29. 23. Kubota H, Okuno R, Hatakeyama K, et al. Moleculer typing of Mycoplasma pneumoniae isolated from pediatric patients in Tokyo, Japan. Jpn J Infect Dis. 2015;68:76-8. 8. Chalker VJ, Pereyre S, Dumke R, et al. International Mycoplasma pneumoniae typing study: interpretation of M. pneumoniae multilocus variable-number tandem-repeat analysis. New Microbes New Infect. 2015;7:37-40. 19. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27-72. 26. Cousin-Allery A, Charron A, de Barbeyrac B, et al. Molecular typing of Mycoplasma pneumoniae strains by PCR-based methods and pulsed-field gel electrophoresis. Application to French and Danish isolates. Epidemiol Infect. 2000;124:103-11. 27. Okazaki N, Narita M, Yamada S, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol. 2001;45:617-20. 20. Diaz MH, Benitez AJ, Winchell JM. Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013. J Clin Microbiol. 2015;53:124-30. 25. Suzuki Y, Itagaki T, Seto J, et al. Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009. Pediatr Infect Dis J. 2013;32:237-40. 11. Xue G, Wang Q, Yan C, et al. Molecular characterizations of PCR-positive Mycoplasma pneumoniae specimens collected from Australia and China. J Clin Microbiol. 2014;52:1478-82. 2. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697-728. 22. Suzuki Y, Seto J, Itagaki T, et al. Gene mutations associated with macrolide-resistance p1 gene typing of Mycoplasma pneumoniae isolated in Yamagata, Japan, between 2004 and 2013. Kansenshogaku Zasshi 2015;89:16-22. Japanese. 9. Sun H, Xue G, Yan C, et al. Changes in molecular characteristics of Mycoplasma pneumoniae in clinical specimens from children in Beijing between 2003 and 2015. PLoS One. 2017;12:e0170253. 17. Zhao F, Cao B, Li J, et al. Sequence analysis of the p1 adhesin gene of Mycoplasma pneumoniae in clinical isolates collected in Beijing in 2008 to 2009. J Clin Microbiol. 2011;49:3000-3. 7. Yamazaki T, Kenri T. Epidemiology of Mycoplasma pneumoniae infections in Japan and therapeutic strategies for macrolide-resistant M. pneumoniae. Front Microbiol. 2016;7:693. 4. Block S, Hedrick J, Hammerschlag MR, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J. 1995;14:471-7. 21. Dumke R, Schnee C, Pletz MW, et al. Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011–2012. Emerg Infect Dis. 2015;21:426-34. 1. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32:956-73. 24. Touati A, Blouin Y, Sirand-Pugnet P, et al. Molecular epidemiology of Mycoplasma pneumoniae: genotyping using single nucleotide polymorphisms and SNaPshot technology. J Clin Microbiol. 2015;53:3182-94. 32. Diaz MH, Desai HP, Morrison SS, et al. Comprehensive bioinformatics analysis of Mycoplasma pneumoniae genomes to investigate underlying population structure and type-specific determinants. PLoS One. 2017;12:e0174701. 28. Pereyre S, Guyot C, Renaudin H, et al. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2004;48:460-5. 29. Ministry of Health, Labour and Welfare and National Institute of Infectious Disease. Mycoplasma Pneumonia. Available at <https://www.niid.go.jp/niid/en/10/2096-weeklygraph/1659-18 myco.html>. Accessed April 9, 2017. Japanese. 30. Qu J, Yu X, Liu Y, et al. Specific multilocus variable-number tandem-repeat analysis genotypes of Mycoplasma pneumoniae are associated with diseases severity and macrolide susceptibility. PLoS One. 2013;8:e82174. 13. Diaz MH, Benitez AJ, Cross KE, et al. Molecular detection and characterization of Mycoplasma pneumoniae among patients hospitalized with community-acquired pneumonia in the United States. Open Forum Infect Dis. 2015;2:ofv106. 16. Kenri T, Ohya H, Horino A, et al. Identification of Mycoplasma pneumoniae type 2b variant strains in Japan. J Med Microbiol. 2012;61:1633-5. 22 23 24 25 26 27 28 29 30 31 10 32 11 33 12 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 21 |
References_xml | – reference: 1. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32:956-73. – reference: 31. Whistler T, Sawatwong P, Diaz MH, et al. Molecular characterization of Mycoplasma pneumoniae infections in two rural populations of Thailand from 2009 to 2012. J Clin Microbiol. 2017;55:2222-33. – reference: 10. Ho PL, Law PY, Chan BW, et al. Emergence of macrolide-resistant Mycoplasma pneumoniae in Hong Kong is linked to increasing macrolide resistance in multilocus variable-number tandem-repeat analysis type 4-5-7-2. J Clin Microbiol. 2015;53:3560-4. – reference: 13. Diaz MH, Benitez AJ, Cross KE, et al. Molecular detection and characterization of Mycoplasma pneumoniae among patients hospitalized with community-acquired pneumonia in the United States. Open Forum Infect Dis. 2015;2:ofv106. – reference: 6. Dégrange S, Cazanave C, Charron A, et al. Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae. J Clin Microbiol. 2009;47:914-23. – reference: 12. Sun H, Xue G, Yan C, et al. Multiple-locus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature. PLoS One. 2013;8:e64607. – reference: 24. Touati A, Blouin Y, Sirand-Pugnet P, et al. Molecular epidemiology of Mycoplasma pneumoniae: genotyping using single nucleotide polymorphisms and SNaPshot technology. J Clin Microbiol. 2015;53:3182-94. – reference: 11. Xue G, Wang Q, Yan C, et al. Molecular characterizations of PCR-positive Mycoplasma pneumoniae specimens collected from Australia and China. J Clin Microbiol. 2014;52:1478-82. – reference: 25. Suzuki Y, Itagaki T, Seto J, et al. Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009. Pediatr Infect Dis J. 2013;32:237-40. – reference: 26. Cousin-Allery A, Charron A, de Barbeyrac B, et al. Molecular typing of Mycoplasma pneumoniae strains by PCR-based methods and pulsed-field gel electrophoresis. Application to French and Danish isolates. Epidemiol Infect. 2000;124:103-11. – reference: 9. Sun H, Xue G, Yan C, et al. Changes in molecular characteristics of Mycoplasma pneumoniae in clinical specimens from children in Beijing between 2003 and 2015. PLoS One. 2017;12:e0170253. – reference: 33. Zhang J, Song X, Ma MJ, et al. Inter- and intra-strain variability of tandem repeats in Mycoplasma pneumoniae based on next-generation sequencing data. Future Microbiol. 2017;12:119-29. – reference: 7. Yamazaki T, Kenri T. Epidemiology of Mycoplasma pneumoniae infections in Japan and therapeutic strategies for macrolide-resistant M. pneumoniae. Front Microbiol. 2016;7:693. – reference: 19. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27-72. – reference: 32. Diaz MH, Desai HP, Morrison SS, et al. Comprehensive bioinformatics analysis of Mycoplasma pneumoniae genomes to investigate underlying population structure and type-specific determinants. PLoS One. 2017;12:e0174701. – reference: 4. Block S, Hedrick J, Hammerschlag MR, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J. 1995;14:471-7. – reference: 23. Kubota H, Okuno R, Hatakeyama K, et al. Moleculer typing of Mycoplasma pneumoniae isolated from pediatric patients in Tokyo, Japan. Jpn J Infect Dis. 2015;68:76-8. – reference: 16. Kenri T, Ohya H, Horino A, et al. Identification of Mycoplasma pneumoniae type 2b variant strains in Japan. J Med Microbiol. 2012;61:1633-5. – reference: 20. Diaz MH, Benitez AJ, Winchell JM. Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013. J Clin Microbiol. 2015;53:124-30. – reference: 30. Qu J, Yu X, Liu Y, et al. Specific multilocus variable-number tandem-repeat analysis genotypes of Mycoplasma pneumoniae are associated with diseases severity and macrolide susceptibility. PLoS One. 2013;8:e82174. – reference: 15. Kenri T, Horino A, Matsui M, et al. Complete genome sequence of Mycoplasma pneumoniae type 2a strain 309, isolated in Japan. J Bacteriol. 2012;194:1253-4. – reference: 29. Ministry of Health, Labour and Welfare and National Institute of Infectious Disease. Mycoplasma Pneumonia. Available at <https://www.niid.go.jp/niid/en/10/2096-weeklygraph/1659-18 myco.html>. Accessed April 9, 2017. Japanese. – reference: 28. Pereyre S, Guyot C, Renaudin H, et al. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2004;48:460-5. – reference: 17. Zhao F, Cao B, Li J, et al. Sequence analysis of the p1 adhesin gene of Mycoplasma pneumoniae in clinical isolates collected in Beijing in 2008 to 2009. J Clin Microbiol. 2011;49:3000-3. – reference: 27. Okazaki N, Narita M, Yamada S, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol. 2001;45:617-20. – reference: 22. Suzuki Y, Seto J, Itagaki T, et al. Gene mutations associated with macrolide-resistance p1 gene typing of Mycoplasma pneumoniae isolated in Yamagata, Japan, between 2004 and 2013. Kansenshogaku Zasshi 2015;89:16-22. Japanese. – reference: 8. Chalker VJ, Pereyre S, Dumke R, et al. International Mycoplasma pneumoniae typing study: interpretation of M. pneumoniae multilocus variable-number tandem-repeat analysis. New Microbes New Infect. 2015;7:37-40. – reference: 2. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697-728. – reference: 18. Pereyre S, Goret J, Bébéar C. Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment. Front Microbiol. 2016;7:974. – reference: 3. Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis. 1993;17:S37-46. – reference: 14. Sasaki T, Kenri T, Okazaki N, et al. Epidemiological study of Mycoplasma pneumoniae infections in Japan based on PCR-restriction fragment length polymorphism of the P1 cytadhesin gene. J Clin Microbiol 1996;34:447-9. – reference: 21. Dumke R, Schnee C, Pletz MW, et al. Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011–2012. Emerg Infect Dis. 2015;21:426-34. – reference: 5. Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology. 2004;9:109-14. – ident: 16 doi: 10.1099/jmm.0.046441-0 – ident: 32 doi: 10.1371/journal.pone.0174701 – ident: 11 doi: 10.1128/JCM.03366-13 – ident: 4 doi: 10.1097/00006454-199506000-00002 – ident: 28 doi: 10.1128/AAC.48.2.460-465.2004 – ident: 17 doi: 10.1128/JCM.00105-11 – ident: 22 doi: 10.11150/kansenshogakuzasshi.89.16 – ident: 31 doi: 10.1128/JCM.00350-17 – ident: 13 doi: 10.1093/ofid/ofv106 – ident: 19 doi: 10.1086/511159 – ident: 23 doi: 10.7883/yoken.JJID.2014.336 – ident: 30 doi: 10.1371/journal.pone.0082174 – ident: 10 doi: 10.1128/JCM.01983-15 – ident: 24 doi: 10.1128/JCM.01156-15 – ident: 18 doi: 10.3389/fmicb.2016.00974 – ident: 25 doi: 10.1097/INF.0b013e31827aa7bd – ident: 7 – ident: 1 doi: 10.1111/j.1574-6976.2008.00129.x – ident: 6 doi: 10.1128/JCM.01935-08 – ident: 3 doi: 10.1093/clinids/17.Supplement_1.S37 – ident: 33 doi: 10.2217/fmb-2016-0111 – ident: 26 doi: 10.1017/S0950268899003313 – ident: 9 doi: 10.1371/journal.pone.0170253 – ident: 21 doi: 10.3201/eid2103.140927 – ident: 20 doi: 10.1128/JCM.02597-14 – ident: 29 – ident: 12 doi: 10.1371/journal.pone.0064607 – ident: 14 doi: 10.1128/JCM.34.2.447-449.1996 – ident: 27 doi: 10.1111/j.1348-0421.2001.tb01293.x – ident: 8 doi: 10.1016/j.nmni.2015.05.005 – ident: 15 doi: 10.1128/JB.06553-11 – ident: 2 doi: 10.1128/CMR.17.4.697-728.2004 – ident: 5 doi: 10.1111/j.1440-1843.2003.00522.x |
SSID | ssj0025510 |
Score | 2.205244 |
Snippet | Multiple-locus variable-number tandem-repeat analysis (MLVA) typing was performed for Mycoplasma pneumoniae strains isolated between 2004 and 2014 in Yamagata,... |
SourceID | proquest pubmed crossref jstage |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 642 |
SubjectTerms | DNA, Bacterial History, 21st Century Humans Japan - epidemiology Loci macrolide resistance Macrolides - pharmacology Microbial Sensitivity Tests Minisatellite Repeats MLVA molecular epidemiology Multilocus Sequence Typing Mutation Mycoplasma pneumoniae Mycoplasma pneumoniae - classification Mycoplasma pneumoniae - drug effects Mycoplasma pneumoniae - genetics Mycoplasma pneumoniae - isolation & purification P1 type Pneumonia, Mycoplasma - epidemiology Pneumonia, Mycoplasma - history Pneumonia, Mycoplasma - microbiology Prevalence Public Health Surveillance Typing VNTR |
Title | Multiple-Locus Variable-Number Tandem-Repeat Analysis of Mycoplasma pneumoniae Isolates between 2004 and 2014 in Yamagata, Japan: Change in Molecular Characteristics during an 11-year Period |
URI | https://www.jstage.jst.go.jp/article/yoken/70/6/70_JJID.2017.276/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/29093323 https://www.proquest.com/docview/2013149498 https://www.proquest.com/docview/1959321846 |
Volume | 70 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Japanese Journal of Infectious Diseases, 2017, Vol.70(6), pp.642-646 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe6gRAviG8KAxmJty4lH67j8Man1opOSHSofYqcxN260aSiyUP3x_G3cRc7XluVifFiRbZ7cnq_2Hfn-yDkjRKhP41S12Ghy6DxAifKpIAPL3XxmixLfAxwHh7zoxM2GPfGrb3WmtdSVSbd9HJnXMn_cBX6gK8YJXsDzlqi0AHPwF9ogcPQ_hOPh8Yb0PlapNWy8wP0XoyEco7rMh-dERqI5w7I2GgGWE8_MlylxQLk5rnsLHJVwYJnUnX6sFoUPa3zFv4L9e0CnN8MLSMTOZensjT-tbCRoEFBByjg8LCptVvf4q_ngbbRkB3Pc1aYPOgbjBUbVUJrgmqpNrNZaF8xeDtzlWR1gO_VZaVrbk8q26dKfZNU5ecz23mGeNRltyfF8mxWygt7GPVLeCFNZrSsymJerdtBdMCn2bQDxhwe6DLGXaX7hGAOiE58fafXJUoMote3ba4zfBkJgGuj6PbhEgqBSS5WxYXKu4NB_xM6BoZdP9yRynvriLWOj6ByIZm4JhIjkRiJxEBkj9zyQdWpy4-MrZsSaHw6o0bzjjpzFhJ5u2MlG9LV7XNQME7V33WnWoYa3Sf3jPJD32skPyAtlT8kd4bGveMR-b0JaLoFaLoBaNoAmhZTegVoegVo2gCaGkBTBDQFIhQBTWc5bQB9SGv0vaMazDhkwUy3wEw1mIEONWCmGsyPycmXz6OPR44pMOKk3BOlM00iIaMsCHoK2kiKVLoyEzLjUgZqmnggKni8l2Q-98NE9EImspSJqOfyFCs5BE_Ifl7k6hmhmVJJ2hPcj5hiXhjAbB55jMkoCXCsTfyGMXFqsu9jEZif8TWQaJND-6OFTj5z_fQPmuN2stmZzOTQjTk2Gz-yczDKEzbVNjlo0BKbz32JkwMP81iJNnlth-EgwttF2BpgF4gxS1WABiNYx1ONMrsOP0LDqR88v9kLvSB38VFbPA_IfvmrUi9BByiTV_VH8gf-JAvr |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multiple-Locus+Variable-Number+Tandem-Repeat+Analysis+of+Mycoplasma+pneumoniae+Isolates+between+2004+and+2014+in+Yamagata%2C+Japan%3A+Change+in+Molecular+Characteristics+during+an+11-year+Period&rft.jtitle=Japanese+journal+of+infectious+diseases&rft.au=Suzuki%2C+Yu&rft.au=Seto%2C+Junji&rft.au=Shimotai%2C+Yoshitaka&rft.au=Itagaki%2C+Tsutomu&rft.date=2017&rft.issn=1344-6304&rft.eissn=1884-2836&rft.volume=70&rft.issue=6&rft.spage=642&rft.epage=646&rft_id=info:doi/10.7883%2Fyoken.JJID.2017.276&rft.externalDBID=n%2Fa&rft.externalDocID=10_7883_yoken_JJID_2017_276 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1344-6304&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1344-6304&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1344-6304&client=summon |